| Parkinson Society Canada’s Webinar on Cognitive Impairment and Parkinson’s Disease was a huge success, thanks to all who participated live. View the archived webinar. Please note: to view the webinar, click “View archived webinar” button, and log in. If you registered prior to the event, enter your email address or if you are a new viewer, enter your details. Read more about the topic and speaker » |
| The Annual General Meeting to the members of Parkinson Society Canada on Friday, May 25, 2012. More » |
| Parkinson Society Canada’s medication card is recognized by the Canadian Air Transport Security Authority (CATSA) as documentation to be presented to screening officers before they begin the screening process. When the card is presented, screening officers will conduct the screening in a sensitive manner. Contact your Parkinson Society Region for a medication card; or download it here » |
| New Clinical Trial in Toronto for men and women diagnosed with Parkinson’s disease. More » |
| Genetic Discrimination has been in the news recently. If you have experienced genetic discrimination because of Parkinson’s, please contact us at info@parkinson.ca. Read “Health insurance and genetic discrimination”. More » |
| Health Canada and Rx&D have developed a national website advising of drug shortages. More » |
| Parkinson's-causing gene discovered at UBC: Scientists at the University of British Columbia have identified a genetic mutation that causes late-onset Parkinson's disease. More » |
| Clinical Trials: Studies Seeking Participants
A study to investigate the efficacy, safety and tolerability of CoganeTM (PYM50028) in early stage Parkinson's disease.
Investigating the D3 Dopamine receptor and its relevance to treatment-induced complications in Parkinson's disease. More »
|
| Many people with Parkinson’s have communication challenges as a result of motor symptoms; but when the person experiences cognitive changes due to non-motor symptoms, it takes a special effort to manage. Learn More » |
|
